TGTX 8-K 2026-01-13

TG THERAPEUTICS, INC. (TGTX) 8-K dated 2026-01-13 — accession 0001437749-26-001194. This URL is the filing, not the TGTX hub.

TG THERAPEUTICS, INC. (TGTX) is a biotechnology company listed on NASDAQ.

TG THERAPEUTICS, INC. filed a 8-K on 2026-01-13. Accession 0001437749-26-001194.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TGTX revenue for 2025-12-31 was $616.3M. Net income was $447.2M. Revenue was up 87.3% from 2024-12-31 to 2025-12-31. TGTX currently screens at market cap $7.88B and trailing P/E 19.4.

Not investment advice. The TGTX SEC hub lists recent forms. The stock page is the research view.